Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction.

MLA

Theiss, Hans D., et al. “Antidiabetic Gliptins in Combination with G-CSF Enhances Myocardial Function and Survival after Acute Myocardial Infarction.” International Journal of Cardiology, vol. 168, no. 4, Oct. 2013, pp. 3359–69. EBSCOhost, https://doi.org/10.1016/j.ijcard.2013.04.121.

APA

Theiss, H. D., Gross, L., Vallaster, M., David, R., Brunner, S., Brenner, C., Nathan, P., Assmann, G., Mueller-Hoecker, J., Vogeser, M., Steinbeck, G., & Franz, W.-M. (2013). Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. International Journal of Cardiology, 168(4), 3359–3369. https://doi.org/10.1016/j.ijcard.2013.04.121

Chicago

Theiss, Hans D, Lisa Gross, Markus Vallaster, Robert David, Stefan Brunner, Christoph Brenner, Petra Nathan, et al. 2013. “Antidiabetic Gliptins in Combination with G-CSF Enhances Myocardial Function and Survival after Acute Myocardial Infarction.” International Journal of Cardiology 168 (4): 3359–69. doi:10.1016/j.ijcard.2013.04.121.